The MarketWatch News Department was not involved in the creation of this content. CHICAGO, Sept. 2, 2025 /PRNewswire/ -- September is Pulmonary Fibrosis Awareness Month, and the American Lung ...
LAFAYETTE HILL, PA. (WPVI) -- Learning you have a life-threatening condition can be frightening. But finding support, and other patients with the disease can make all the difference in navigating it.
September has been designated as Pulmonary Fibrosis Awareness Month, a time to raise awareness about this disease, its symptoms, treatment options, and the need for support. Pulmonary fibrosis is a ...
In 2025, respiratory news highlighted advances in lung imaging, expanded support for pulmonary rehabilitation and promising ...
Pulmonary fibrosis (PF) is a type of interstitial lung disease that causes lung tissue to scar, thicken, and stiffen. It can make breathing difficult and interfere with oxygen absorption into the ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
If you have scarring in your lungs, you may have been diagnosed with pulmonary fibrosis. When the reason for this scarring is unknown, your condition is called idiopathic pulmonary fibrosis (IPF). You ...
Cystic fibrosis (CF) and pulmonary fibrosis (PF) are two chronic conditions that damage the lungs. Treatment for both aims to improve breathing, manage symptoms, and prevent further lung damage. Your ...
CHICAGO, Sept. 2, 2025 /PRNewswire/ -- September is Pulmonary Fibrosis Awareness Month, and the American Lung Association today announced a new educational program to help people living with pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback